期刊文献+

VEGF_(165)的载体构建、表达及其生物学活性 被引量:1

Expression and biological activity test of the VEGF_(165)
在线阅读 下载PDF
导出
摘要 目的:构建血管内皮生长因子(VEGF)165原核表达载体,在大肠杆菌中表达,获得重组VEGF165,并通过细胞和鸡胚尿囊膜试验鉴定其生物学活性。方法:本实验室保存的T-VEGF165质粒,经BamHⅠ和EcoRⅠ双酶切,将其克隆至原核表达载体pET28a(+)中,获得含人VEGF165全序列基因的表达载体pET28a(+)-VEGF165,将其转化至大肠杆菌BL21(DE3),用IPTG诱导表达,对表达产物进行纯化,获得VEGF165蛋白。通过体外促进HUVEC细胞增殖及鸡胚尿囊膜血管增生实验鉴定其生物学活性。结果:成功构建了VEGF165蛋白的原核表达载体,表达纯化了VEGF165蛋白,经过细胞增殖试验及鸡胚尿囊膜血管增生实验,证明该蛋白具有良好的促进血管内皮细胞增殖的生物学活性。结论:成功地获得了人VEGF重组蛋白,并证实了该蛋白具有促进血管内皮细胞增殖活性。 Objective: To construct expression vector of vascular endothelial growth factor165, and express in Escherichia coli ( E. coli). The biological activity of this protein was tested by cell test and effect of chicken embryo allantoic membrane (CAM). Methods: T- VEGF165 was digested by restriction endonucleases, Then it was cloned into pET-28a( + ) expression vector, and transformed into Escherichia coli (E. coli) DH5α. The plasmid DNA was extracted, and The right insertion was retransformed into E. coli BL21 (DE3). The cultures induced by Isopropy-β-D-thiogalactoside(IPTG) was purified and renaturated on the Ni^2+ -NTA resin. The biological activity of VEGF165 was tested through the effect on proliferation of human umbilical vascular endothelial ceil (HUVEC) and the CAM. Results: Expression recombinants of VEGF165 were obtained. This protein has the biological activity of promote angiogenesis. Conclusion: The VEGF165 expressed in E. coli, and the protein possesses the activity of promote angiogenesis
出处 《江苏大学学报(医学版)》 CAS 2007年第2期121-123,共3页 Journal of Jiangsu University:Medicine Edition
作者简介 陈小波(1982-),男,江苏沭阳人,硕士研究生;康向东(联系人),教授,硕士生导师,E-mail:Xd_kang@msn。
  • 相关文献

参考文献5

  • 1Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen[J].Science,1989,246 (4935):1306-1309.
  • 2Tischer E,Mitchell R,Hartman T,et al.The human gene for vascular endothelial growth factor:multiple protein forms are encoded through alternative exon splicing[J].J Biolchem,1991,266(18):11947-11954.
  • 3Staria C,Patel M,Katz B,et al.Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen(r)) in diabetic retinopathy[J].Dev Ophthalmol,2007,39 (1):122-148.
  • 4Henry TD,Annex BH,Azrin MA,et al.Ponble blind placebo controlled trial of recombinant human vascular endothelial growth factor:the V IVA Trial[J].AM Coll Cardiol,1999,33(supp1A):384.
  • 5Koransky ML,Robbins RC,Blau HM.VEGF gene delivery for treatment of ischemic cardiovascular disease[J].Trends Cardio Vasc Med,2002 12 (3):108-114.

同被引文献15

  • 1BROWN L F, DETMAR M, CLAFFEY K, et al. Vascular perme ability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine[J]. Regulation of Angiogenesis, 1997,79 (2) : 233-269.
  • 2ASANO M, YUKITA A, MATSUMOTO T, et al. Inhibition of tumor growth and metastasis by an immunoneutral- izing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121[-J7. Cancer Research, 1995(55) : 5296-5302.
  • 3SHINKARUK S,BAYLE M, LAIN G, et al. Vascular endothelial cell growth factor (VEGF) : An emerging target for cancer chemotherapy[J]. Current Medicinal Chemistry-Anti-Cancer Agents, 2003,3 (2):95-117.
  • 4ARKONAC B M, FOSTER L C, SIBINGA N E, et al. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial eells[J]. Journal of Biological Chemistry, 1998, 273(8) : 4400-4405.
  • 5BERNADETTE F, YOLMARI L C, DOMENICO C, et al. Intradermal delivery of plasmid VEGF165 by electropo- ration promotes wound healing[J]. Molecular Therapy, 2009,17 (4) : 651-657.
  • 6HSU J Y, WAKELEE H A. Monoclonal antibodies targeting vascular endothelial growth factor: Current status and future challenges in cancer therapy[J]. BioDrugs, 2009,23(5) .. 289-304.
  • 7PARIKH S S, MEHTAL H H, DESAI B I. Advances in development of bevacizumab a humanized antiangiogenic therapeutic monoclonal antibody targeting VEGF in cancer cells[J]. International Journal of Pharmacy and Biomed- ical Sciences,2012,3(4) .. 155-163.
  • 8崔斐,李军,罗荣城.贝伐单抗在肿瘤临床治疗中的研究进展[J].河北医学,2008,14(6):741-746. 被引量:9
  • 9张经余,王爱娥,李美香,戴建武.人NANOGP8蛋白的原核表达及多克隆抗体的制备[J].中国生物工程杂志,2009,29(3):30-35. 被引量:4
  • 10赵小峰,董浩,黄晓平,许瑞安,刁勇.以VEGF/VEGFR为靶点的肝癌药物研究进展[J].海峡药学,2009,21(7):22-25. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部